PJ

Peter Jojimon

Active Director Director DIN 07869289
DIN 07869289 First appointment Aug 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Peter Jojimon

Data last updated:

Peter Jojimon is a Director at Sjbs Home Health Care Private Limited (since 2017). The company operates in Healthcare. Sjbs Home Health Care Private Limited reported revenue of ₹2.81 Cr (FY 2022).

DIN 07869289
Primary Designation Director
Industry Healthcare
First Appointment 09 Aug 2017
Oldest Company Age 9 yrs
Largest company Sjbs Home Health Care Private Limited · ₹2.81 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20172017₹2.81 Cr (FY 2022)Active

Board colleagues of Peter Jojimon

Directorship timeline

Open interactive timeline →
Sjbs Home Health Care Private Limited
Premium access

Shareholding and investment profile for Peter Jojimon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peter Jojimon

Peter Jojimon currently holds 1 directorship: Sjbs Home Health Care Private Limited (Director, since 09 Aug 2017, revenue ₹2.81 Cr (FY 2022)).

Peter Jojimon was first appointed on 09 Aug 2017 as Director at Sjbs Home Health Care Private Limited.

The current boards of Peter Jojimon's companies include Aji Francis (Sjbs Home Health Care Private Limited), Govindarajalu Senthamaraikannan (Sjbs Home Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available